The Japanese Pharmaceutical Industry, L. G. Thomas, III.

The Japanese Pharmaceutical Industry, L. G. Thomas, III. Review of Industrial Organization 22: 85–87, 2003. Book Review The Japanese Pharmaceutical Industry, L. G. Thomas, III. Cheltenham, U.K.: Edward Elgar Publishing, 2001, 232 pages, $80. The story Thomas tells is rather alarming. Early in the 1970s, the United States ex- perienced a well-documented lag in the introduction of new drugs. It took the FDA many years to eliminate that lag. During the past decade such a lag has emerged again – this time in Japan. In this slim volume, Thomas analyzes the nature, causes, and consequences of the new drug lag in Japan, drawing attention to the powerful role of Japanese domestic politics in shaping pharmaceutical practices in that na- tion. According to Thomas, more than 80 percent of the significant pharmaceutical innovations in recent years are unavailable in Japan, denying patients the benefits of important new treatments. Thomas focuses attention on innovations that have been approved for use in six or more nations – drugs he terms “global”. He reports that a mere 13 percent of the products that have gained global acceptance since 1995 were available in Japan in 2000. Looking back to 1990, only 33 percent of the products that had gained global acceptance were http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Review of Industrial Organization Springer Journals

The Japanese Pharmaceutical Industry, L. G. Thomas, III.

Loading next page...
 
/lp/springer_journal/the-japanese-pharmaceutical-industry-l-g-thomas-iii-9c3obsRjxq
Publisher
Kluwer Academic Publishers
Copyright
Copyright © 2003 by Kluwer Academic Publishers
Subject
Economics; Industrial Organization; Microeconomics
ISSN
0889-938X
eISSN
1573-7160
D.O.I.
10.1023/A:1022106432261
Publisher site
See Article on Publisher Site

Abstract

Review of Industrial Organization 22: 85–87, 2003. Book Review The Japanese Pharmaceutical Industry, L. G. Thomas, III. Cheltenham, U.K.: Edward Elgar Publishing, 2001, 232 pages, $80. The story Thomas tells is rather alarming. Early in the 1970s, the United States ex- perienced a well-documented lag in the introduction of new drugs. It took the FDA many years to eliminate that lag. During the past decade such a lag has emerged again – this time in Japan. In this slim volume, Thomas analyzes the nature, causes, and consequences of the new drug lag in Japan, drawing attention to the powerful role of Japanese domestic politics in shaping pharmaceutical practices in that na- tion. According to Thomas, more than 80 percent of the significant pharmaceutical innovations in recent years are unavailable in Japan, denying patients the benefits of important new treatments. Thomas focuses attention on innovations that have been approved for use in six or more nations – drugs he terms “global”. He reports that a mere 13 percent of the products that have gained global acceptance since 1995 were available in Japan in 2000. Looking back to 1990, only 33 percent of the products that had gained global acceptance were

Journal

Review of Industrial OrganizationSpringer Journals

Published: Oct 4, 2004

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off